ReviewHuman genomics2026
ExposoGenomics: integrating genome and exposome as jointly dynamic systems for causal discovery and precision health.
Review in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The past decade has witnessed an unprecedented convergence of exposomic technologies, population-scale genomics, and AI-enabled data science, creating the conditions for a new integrative discipline. Here we introduce ExposoGenomics, defined as the integrative study of how the genome and exposome, treated as jointly dynamic systems, interact across the life course to shape health and disease. ExposoGenomics moves beyond classical gene-environment interaction models by embedding high-dimensional, temporally resolved exposure data within a multi-omic and AI-enabled analytical architecture oriented toward causal discovery, mechanistic understanding, and translational application. We describe the conceptual foundations of this framework, its mechanistic architecture linking external exposures to genomic responses through physiologically based kinetic models and adverse outcome networks, and the analytical approaches, including causal machine learning, graph-based integration, and foundation models, required to realize its potential. We emphasize that computational prediction must be accompanied by rigorous empirical validation, and that findings must be grounded in biologically plausible, causally supported mechanisms. In conjunction with this Perspective, Human Genomics formally launches ExposoGenomics as a dedicated article category and invites submissions that advance this integrative agenda.
Indexed as
Identifiers
42482117What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.